Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard C Herrmann

Showing results (251-260 of 306) with videos related to

Pageof 31
Sort By:
European Heart Journal. Cardiovascular Imaging|May 2, 2024
Left and right ventricular longitudinal systolic function following aortic valve replacement in the PARTNER 2 trial and registryIria Silva, Julien Ternacle, Rebecca T Hahn, et al.
JACC. Cardiovascular Interventions|July 12, 2023
First-in-Human Multicenter Experience of the Newest Generation Supra-Annular Self-Expanding Evolut FX TAVR SystemSyed Zaid, Guilherme F Attizzani, Parasuram Krishnamoorthy, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 30, 2022
Two-year clinical outcomes after successful transcatheter aortic valve implantation with balloon-expandable versus self-expanding valves: A subanalysis of the GALILEO trialTaishi Okuno, George D Dangas, Christian Hengstenberg, et al.
Circulation. Population Health and Outcomes|January 19, 2026
Estimating the Placebo Effect on Patient-Reported Outcomes in Sham-controlled Device Trials: Insights from REDUCE LAP-HF IIAndrew A Girard, Uma Mylavarapu, Jan Komtebedde, et al.
The Annals of Thoracic Surgery|December 18, 2024
Five- Year Outcomes in Low-Risk Patients Undergoing Surgery in the PARTNER 3 TrialVinod H Thourani, Martin B Leon, Raj Makkar, et al.
Journal of the American Heart Association|March 18, 2026
Simple Index for Identifying Patients at Increased Risk of Suboptimal Forward-Flow Hemodynamics After Transcatheter Aortic Valve ReplacementPier Pasquale Leone, Damiano Regazzoli, Matteo Sturla, et al.
Journal of the American College of Cardiology|March 5, 2021
Outcomes 2 Years After Transcatheter Aortic Valve Replacement in Patients at Low Surgical RiskMartin B Leon, Michael J Mack, Rebecca T Hahn, et al.
European Heart Journal|May 19, 2016
Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic stenosisSusheel Kodali, Vinod H Thourani, Jonathon White, et al.
Circulation. Cardiovascular Interventions|July 18, 2020
Outcome of Flow-Gradient Patterns of Aortic Stenosis After Aortic Valve Replacement: An Analysis of the PARTNER 2 Trial and RegistryErwan Salaun, Marie-Annick Clavel, Rebecca T Hahn, et al.
The Annals of Thoracic Surgery|August 6, 2015
Outcomes in Nonagenarians Undergoing Transcatheter Aortic Valve Replacement in the PARTNER-I TrialVinod H Thourani, Hanna A Jensen, Vasilis Babaliaros, et al.
Pageof 31

Showing results (251-260 of 306) with videos related to

Sort By:
Pageof 31
European Heart Journal. Cardiovascular Imaging|May 2, 2024
Left and right ventricular longitudinal systolic function following aortic valve replacement in the PARTNER 2 trial and registryIria Silva, Julien Ternacle, Rebecca T Hahn, et al.
JACC. Cardiovascular Interventions|July 12, 2023
First-in-Human Multicenter Experience of the Newest Generation Supra-Annular Self-Expanding Evolut FX TAVR SystemSyed Zaid, Guilherme F Attizzani, Parasuram Krishnamoorthy, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 30, 2022
Two-year clinical outcomes after successful transcatheter aortic valve implantation with balloon-expandable versus self-expanding valves: A subanalysis of the GALILEO trialTaishi Okuno, George D Dangas, Christian Hengstenberg, et al.
Circulation. Population Health and Outcomes|January 19, 2026
Estimating the Placebo Effect on Patient-Reported Outcomes in Sham-controlled Device Trials: Insights from REDUCE LAP-HF IIAndrew A Girard, Uma Mylavarapu, Jan Komtebedde, et al.
The Annals of Thoracic Surgery|December 18, 2024
Five- Year Outcomes in Low-Risk Patients Undergoing Surgery in the PARTNER 3 TrialVinod H Thourani, Martin B Leon, Raj Makkar, et al.
Journal of the American Heart Association|March 18, 2026
Simple Index for Identifying Patients at Increased Risk of Suboptimal Forward-Flow Hemodynamics After Transcatheter Aortic Valve ReplacementPier Pasquale Leone, Damiano Regazzoli, Matteo Sturla, et al.
Journal of the American College of Cardiology|March 5, 2021
Outcomes 2 Years After Transcatheter Aortic Valve Replacement in Patients at Low Surgical RiskMartin B Leon, Michael J Mack, Rebecca T Hahn, et al.
European Heart Journal|May 19, 2016
Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic stenosisSusheel Kodali, Vinod H Thourani, Jonathon White, et al.
Circulation. Cardiovascular Interventions|July 18, 2020
Outcome of Flow-Gradient Patterns of Aortic Stenosis After Aortic Valve Replacement: An Analysis of the PARTNER 2 Trial and RegistryErwan Salaun, Marie-Annick Clavel, Rebecca T Hahn, et al.
The Annals of Thoracic Surgery|August 6, 2015
Outcomes in Nonagenarians Undergoing Transcatheter Aortic Valve Replacement in the PARTNER-I TrialVinod H Thourani, Hanna A Jensen, Vasilis Babaliaros, et al.
Pageof 31